表紙：網膜芽細胞腫治療市場規模：疾患タイプ、病期、治療タイプ、エンドユーザー別＆世界予測、2024年～2032年

市場調査レポート

商品コード

1411271

網膜芽細胞腫治療市場規模：疾患タイプ、病期、治療タイプ、エンドユーザー別＆世界予測、2024年～2032年

Retinoblastoma Treatment Market Size - By Disease Type (Non-hereditary, Hereditary), Disease Stage (Intraocular, Extraocular), Treatment Type (Chemotherapy, Radiation, Surgery, Laser, Cryotherapy), End-user & Global Forecast, 2024 - 2032

出版日: 2023年12月18日
発行: Global Market Insights Inc.
ページ情報: 英文 150 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 4,850 712,077円

レポートPDFおよびExcelを1名様のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Multi User License)

USD 6,050 888,261円

レポートPDFおよびExcelを5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Enterprise User License)

USD 8,350 1,225,947円

レポートPDFおよびExcelを同一企業内のすべての方にご利用頂けるライセンスです。 100％子会社は同一企業とみなされます。 PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

網膜芽細胞腫治療市場規模は、2024年から2032年にかけてCAGR 4.7％で拡大すると予測されます。

医学研究と技術の進歩が進み、早期診断と個別化治療への道が開かれつつあります。網膜芽細胞腫に対する意識の高まりとヘルスケアインフラの改善が相まって、患者へのアクセシビリティと治療率の向上に寄与しています。

ヘルスケア機関、研究機関、および製薬企業間の協力的な取り組みの急増は、網膜芽細胞腫治療法のような革新的な治療法の開発に拍車をかけています。小児ヘルスケアへの注目の高まりは、早期スクリーニングと早期介入を促進するためのいくつかのイニシアチブにつながっています。さらに、腫瘍学研究への継続的な投資、遺伝子治療や標的治療への重点の高まりが、業界の成長を増大させるであろう。

網膜芽細胞腫治療市場は、疾患タイプ、病期、治療タイプ、エンドユーザー、地域に分類されます。

疾患タイプに基づくと、遺伝性網膜芽細胞腫セグメントの産業価値は、2024年から2032年にかけて3.9％のCAGRを示すと予測されています。これは、疾患の早期発見を可能にする遺伝子検査の進歩の高まりによるものです。遺伝性網膜芽細胞腫症例の増加と相まって、遺伝的要因の理解が進み、標的治療に対する需要が高まっています。さらに、現在進行中の研究開発活動は、個別化医療への注目の高まりとともに、遺伝性網膜芽細胞腫の治療に対する製品需要に拍車をかけると思われます。

レーザー治療による網膜芽細胞腫治療の市場シェアは、2024年から2032年にかけてCAGR 3.7％で上昇すると予測されています。これは、効果的な腫瘍制御を提供するレーザー治療の非侵襲性と精度に起因します。健康な組織へのダメージを最小限に抑えるレーザー技術の進歩は、網膜芽細胞腫のさまざまな治療オプションの採用を促進すると思われます。

地域別では、アジア太平洋の網膜芽細胞腫治療産業の規模は、2024年から2032年までのCAGRが5.4％になると予測されています。この成長は、ヘルスケアインフラの発展、小児眼疾患に対する意識の高まり、先進医療へのアクセスの改善に起因しています。人口の増加とヘルスケア投資の急増は、この地域における網膜芽細胞腫治療の適用を増加させるであろう。さらに、医学研究における強固な共同努力と治療オプションの進歩も、この地域の産業を後押しすると思われます。

業界情勢
業界への影響要因
- 促進要因
  - 網膜芽細胞腫の発生率の増加
  - 網膜芽細胞腫の早期診断と治療
- 業界の潜在的リスク＆課題
  - 高い治療費
  - 網膜芽細胞腫治療に伴う副作用
成長の可能性分析
- 疾患タイプ別
- 病期別
- 治療タイプ別
- エンドユーザー別
規制状況
パイプライン分析
ポーター分析
PESTEL分析

第4章競合情勢

イントロダクション
企業マトリックス分析
主要市場プレーヤーの競合分析
競合のポジショニングマトリックス
戦略ダッシュボード

第5章網膜芽細胞腫治療市場推定・主要動向予測：疾患タイプ別、2018年～2032年

主要動向：疾患タイプ別
非遺伝性網膜芽細胞腫
遺伝性網膜芽細胞腫

第6章網膜芽細胞腫治療市場の推定・予測：病期別、2018-2032年

主要動向：病期別
眼内網膜芽細胞腫
眼外網膜芽細胞腫

第7章網膜芽細胞腫治療市場の推定・予測：治療タイプ別、2018-2032年

主要動向：治療タイプ別
化学療法
放射線療法
外科療法
レーザー療法
凍結療法

第8章網膜芽細胞腫治療市場推計・予測：エンドユーザー別、2018年～2032年

主要動向：エンドユーザー別
病院
がん治療センター
眼科専門クリニック

第9章網膜芽細胞腫治療市場の推定・予測：地域別、2018年～2032年

主要動向：地域別
北米
- 米国
- カナダ
欧州
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- その他欧州
アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- メキシコ
- その他ラテンアメリカ
中東・アフリカ
- 南アフリカ
- サウジアラビア
- その他中東とアフリカ

第10章企業プロファイル

Baxter International Inc.
Bristol-Myers Squibb Company
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Cadila Pharmaceuticals
Cellceutix Corporation

図表

Data Tables

TABLE 1 Market revenue, by disease type (2023)
TABLE 2 Market revenue, by disease stage (2023)
TABLE 3 Market revenue, by treatment type (2023)
TABLE 4 Market revenue, by end-user (2023)
TABLE 5 Market share, by region (2023)
TABLE 6 Global retinoblastoma treatment market size, by region, 2018 - 2023 (USD Million)
TABLE 7 Global retinoblastoma treatment market size, by region, 2024 - 2032 (USD Million)
TABLE 8 Global retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 9 Global retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 10 Global retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 11 Global retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 12 Global retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 13 Global retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 14 Global retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 15 Global retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 16 Industry impact forces
TABLE 17 Non-hereditary retinoblastoma market size, 2018 - 2023 (USD Million)
TABLE 18 Non-hereditary retinoblastoma market size, 2024 - 2032 (USD Million)
TABLE 19 Hereditary retinoblastoma market size, 2018 - 2023 (USD Million)
TABLE 20 Hereditary retinoblastoma market size, 2024 - 2032 (USD Million)
TABLE 21 Intraocular retinoblastoma market size, 2018 - 2023 (USD Million)
TABLE 22 Intraocular retinoblastoma market size, 2024 - 2032 (USD Million)
TABLE 23 Extraocular retinoblastoma market size, 2018 - 2023 (USD Million)
TABLE 24 Extraocular retinoblastoma market size, 2024 - 2032 (USD Million)
TABLE 25 Chemotherapy market size, 2018 - 2023 (USD Million)
TABLE 26 Chemotherapy market size, 2024 - 2032 (USD Million)
TABLE 27 Radiation therapy market size, 2018 - 2023 (USD Million)
TABLE 28 Radiation therapy market size, 2024 - 2032 (USD Million)
TABLE 29 Surgery market size, 2018 - 2023 (USD Million)
TABLE 30 Surgery market size, 2024 - 2032 (USD Million)
TABLE 31 Laser therapy market size, 2018 - 2023 (USD Million)
TABLE 32 Laser therapy market size, 2024 - 2032 (USD Million)
TABLE 33 Cryotherapy market size, 2018 - 2023 (USD Million)
TABLE 34 Cryotherapy market size, 2024 - 2032 (USD Million)
TABLE 35 Hospitals market size, 2018 - 2023 (USD Million)
TABLE 36 Hospitals market size, 2024 - 2032 (USD Million)
TABLE 37 Cancer treatment centers market size, 2018 - 2023 (USD Million)
TABLE 38 Cancer treatment centers market size, 2024 - 2032 (USD Million)
TABLE 39 Specialty eye clinics market size, 2018 - 2023 (USD Million)
TABLE 40 Specialty eye clinics market size, 2024 - 2032 (USD Million)
TABLE 41 North America retinoblastoma treatment market size, by country, 2018 - 2023 (USD Million)
TABLE 42 North America retinoblastoma treatment market size, by country, 2024 - 2032 (USD Million)
TABLE 43 North America retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 44 North America retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 45 North America retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 46 North America retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 47 North America retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 48 North America retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 49 North America retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 50 North America retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 51 U.S. retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 52 U.S. retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 53 U.S. retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 54 U.S. retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 55 U.S. retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 56 U.S. retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 57 U.S. retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 58 U.S. retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 59 Canada retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 60 Canada retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 61 Canada retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 62 Canada retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 63 Canada retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 64 Canada retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 65 Canada retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 66 Canada retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 67 Europe retinoblastoma treatment market size, by country, 2018 - 2023 (USD Million)
TABLE 68 Europe retinoblastoma treatment market size, by country, 2024 - 2032 (USD Million)
TABLE 69 Europe retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 70 Europe retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 71 Europe retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 72 Europe retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 73 Europe retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 74 Europe retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 75 Europe retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 76 Europe retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 77 Germany retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 78 Germany retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 79 Germany retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 80 Germany retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 81 Germany retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 82 Germany retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 83 Germany retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 84 Germany retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 85 UK retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 86 UK retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 87 UK retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 88 UK retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 89 UK retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 90 UK retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 91 UK retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 92 UK retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 93 France retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 94 France retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 95 France retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 96 France retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 97 France retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 98 France retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 99 France retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 100 France retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 101 Spain retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 102 Spain retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 103 Spain retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 104 Spain retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 105 Spain retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 106 Spain retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 107 Spain retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 108 Spain retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 109 Italy retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 110 Italy retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 111 Italy retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 112 Italy retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 113 Italy retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 114 Italy retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 115 Italy retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 116 Italy retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 117 Rest of Europe retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 118 Rest of Europe retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 119 Rest of Europe retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 120 Rest of Europe retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 121 Rest of Europe retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 122 Rest of Europe retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 123 Rest of Europe retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 124 Rest of Europe retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 125 Asia Pacific retinoblastoma treatment market size, by country, 2018 - 2023 (USD Million)
TABLE 126 Asia Pacific retinoblastoma treatment market size, by country, 2024 - 2032 (USD Million)
TABLE 127 Asia Pacific retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 128 Asia Pacific retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 129 Asia Pacific retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 130 Asia Pacific retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 131 Asia Pacific retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 132 Asia Pacific retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 133 Asia Pacific retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 134 Asia Pacific retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 135 China retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 136 China retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 137 China retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 138 China retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 139 China retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 140 China retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 141 China retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 142 China retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 143 Japan retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 144 Japan retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 145 Japan retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 146 Japan retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 147 Japan retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 148 Japan retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 149 Japan retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 150 Japan retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 151 India retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 152 India retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 153 India retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 154 India retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 155 India retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 156 India retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 157 India retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 158 India retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 159 Australia retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 160 Australia retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 161 Australia retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 162 Australia retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 163 Australia retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 164 Australia retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 165 Australia retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 166 Australia retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 167 Rest of Asia Pacific retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 168 Rest of Asia Pacific retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 169 Rest of Asia Pacific retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 170 Rest of Asia Pacific retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 171 Rest of Asia Pacific retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 172 Rest of Asia Pacific retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 173 Rest of Asia Pacific retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 174 Rest of Asia Pacific retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 175 Latin America retinoblastoma treatment market size, by country, 2018 - 2023 (USD Million)
TABLE 176 Latin America retinoblastoma treatment market size, by country, 2024 - 2032 (USD Million)
TABLE 177 Latin America retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 178 Latin America retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 179 Latin America retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 180 Latin America retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 181 Latin America retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 182 Latin America retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 183 Latin America retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 184 Latin America retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 185 Brazil retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 186 Brazil retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 187 Brazil retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 188 Brazil retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 189 Brazil retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 190 Brazil retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 191 Brazil retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 192 Brazil retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 193 Mexico retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 194 Mexico retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 195 Mexico retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 196 Mexico retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 197 Mexico retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 198 Mexico retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 199 Mexico retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 200 Mexico retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 201 Rest of Latin America retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 202 Rest of Latin America retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 203 Rest of Latin America retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 204 Rest of Latin America retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 205 Rest of Latin America retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 206 Rest of Latin America retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 207 Rest of Latin America retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 208 Rest of Latin America retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 209 Middle East & Africa retinoblastoma treatment market size, by country, 2018 - 2023 (USD Million)
TABLE 210 Middle East & Africa retinoblastoma treatment market size, by country, 2024 - 2032 (USD Million)
TABLE 211 Middle East & Africa retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 212 Middle East & Africa retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 213 Middle East & Africa retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 214 Middle East & Africa retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 215 Middle East & Africa retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 216 Middle East & Africa retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 217 Middle East & Africa retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 218 Middle East & Africa retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 219 South Africa retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 220 South Africa retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 221 South Africa retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 222 South Africa retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 223 South Africa retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 224 South Africa retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 225 South Africa retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 226 South Africa retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 227 Saudi Arabia retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 228 Saudi Arabia retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 229 Saudi Arabia retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 230 Saudi Arabia retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 231 Saudi Arabia retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 232 Saudi Arabia retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 233 Saudi Arabia retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 234 Saudi Arabia retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)
TABLE 235 Rest of Middle East & Africa retinoblastoma treatment market size, by disease type, 2018 - 2023 (USD Million)
TABLE 236 Rest of Middle East & Africa retinoblastoma treatment market size, by disease type, 2024 - 2032 (USD Million)
TABLE 237 Rest of Middle East & Africa retinoblastoma treatment market size, by disease stage, 2018 - 2023 (USD Million)
TABLE 238 Rest of Middle East & Africa retinoblastoma treatment market size, by disease stage, 2024 - 2032 (USD Million)
TABLE 239 Rest of Middle East & Africa retinoblastoma treatment market size, by treatment type, 2018 - 2023 (USD Million)
TABLE 240 Rest of Middle East & Africa retinoblastoma treatment market size, by treatment type, 2024 - 2032 (USD Million)
TABLE 241 Rest of Middle East & Africa retinoblastoma treatment market size, by end-user, 2018 - 2023 (USD Million)
TABLE 242 Rest of Middle East & Africa retinoblastoma treatment market size, by end-user, 2024 - 2032 (USD Million)

Charts & Figures

FIG 1 GMI report coverage: critical research elements
FIG 2 Top-down approach
FIG 3 Market estimation and forecast methodology
FIG 4 Market forecasting methodology
FIG 5 Breakdown of primary participants
FIG 6 Retinoblastoma treatment industry 360 degree synopsis, 2018 - 2032
FIG 7 Growth potential analysis, by disease type
FIG 8 Growth potential analysis, by disease stage
FIG 9 Growth potential analysis, by treatment type
FIG 10 Growth potential analysis, by end-user
FIG 11 Porter's analysis
FIG 12 PESTEL analysis
FIG 13 Company matrix analysis, 2023
FIG 14 Competitive analysis of major market players, 2023
FIG 15 Competitive positioning matrix, 2023
FIG 16 Strategic dashboard, 2023

Product Code: 7698

Retinoblastoma treatment market size is projected to expand at 4.7% CAGR from 2024 to 2032. The increasing advancements in medical research and technology are making way for early diagnosis and personalized treatment approaches. The rising awareness about retinoblastoma coupled with improved healthcare infrastructure is contributing to higher patient accessibility and treatment rates.

The jump in collaborative efforts among healthcare organizations, research institutions, and pharmaceutical companies is fueling the development of innovative therapies, such as retinoblastoma treatment therapies. The surging focus on pediatric healthcare is leading to several initiatives for promoting early screening and intervention. Additionally, the ongoing investments in oncology research and the growing emphasis on gene therapy and targeted therapies will augment the industry growth.

The retinoblastoma treatment market is segregated into disease type, disease stage, treatment type, end-user, and region.

Based on disease type, the industry value from the hereditary retinoblastoma segment is projected to witness 3.9% CAGR from 2024 to 2032. This is due to the rising advancements in genetic testing for enabling early disease detection. The increasing understanding of genetic factors coupled with the rise in hereditary retinoblastoma cases is amplifying the demand for targeted therapies. Moreover, the ongoing R&D activities, along with the rising focus on personalized medicine will fuel the product demand for treatment of hereditary retinoblastoma.

Retinoblastoma treatment market share from the laser therapy treatment segment is anticipated to rise at 3.7% CAGR from 2024 to 2032, owing to the non-invasiveness and precision of laser therapy for providing effective tumor control. The increasing advancements in laser technology along with its ability to minimize damages to healthy tissues will drive the adoption of various treatment options for retinoblastoma.

Regionally, the Asia Pacific retinoblastoma treatment industry size is projected to depict 5.4% CAGR from 2024 to 2032. The growth can be attributed to the healthcare infrastructure developments, rising awareness about pediatric eye diseases, and improved accessibility to advanced medical treatments. The growing population and the surge in healthcare investments will increase the applications of retinoblastoma treatment in the region. Additionally, the robust collaborative efforts in medical research and advancements in treatment options will also boost the regional industry.

Chapter 1 Methodology & Scope

1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data validation
1.5 Data sources
- 1.5.1 Primary
- 1.5.2 Secondary
  - 1.5.2.1 Paid sources
  - 1.5.2.2 Public sources

Chapter 2 Executive Summary

2.1 Retinoblastoma treatment industry 360 degree synopsis, 2018 - 2032 (USD Million)
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Disease type trends
- 2.1.4 Disease stage trends
- 2.1.5 Treatment trends
- 2.1.6 End-user trends

Chapter 3 Retinoblastoma Treatment Market Insights

3.1 Industry landscape, 2018 - 2032 (USD Million)
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing incidence of retinoblastoma
  - 3.2.1.2 Early diagnosis and treatment of retinoblastoma
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High treatment cost
  - 3.2.2.2 Side effects associated with retinoblastoma treatment
3.3 Growth potentialanalysis
- 3.3.1 By disease type
- 3.3.2 By disease stage
- 3.3.3 By treatment type
- 3.3.4 By end-user
3.4 Regulatory landscape
3.5 Pipelineanalysis
3.6 Porter'sanalysis
3.7 PESTELanalysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrixanalysis, 2023
4.3 Competitiveanalysis of major market players, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic dashboard, 2023

Chapter 5 Retinoblastoma Treatment Market Estimates and Forecast, By Disease Type, 2018-2032 (USD Million)

5.1 Key trends, by disease type
5.2 Non-hereditary retinoblastoma
5.3 Hereditary retinoblastoma

Chapter 6 Retinoblastoma Treatment Market Estimates and Forecast, By Disease Stage, 2018-2032 (USD Million)

6.1 Key trends, by disease stage
6.2 Intraocular retinoblastoma
6.3 Extraocular retinoblastoma

Chapter 7 Retinoblastoma Treatment Market Estimates and Forecast, By Treatment Type, 2018-2032 (USD Million)

7.1 Key trends, by treatment type
7.2 Chemotherapy
7.3 Radiation therapy
7.4 Surgery
7.5 Laser therapy
7.6 Cryotherapy

Chapter 8 Retinoblastoma Treatment Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)

8.1 Key trends, by end-user
8.2 Hospitals
8.3 Cancer treatment centers
8.4 Specialty eye clinics

Chapter 9 Retinoblastoma Treatment Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East & Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

10.1 Baxter International Inc.
10.2 Bristol-Myers Squibb Company
10.3 GlaxoSmithKline plc
10.4 Johnson & Johnson
10.5 Merck & Co., Inc.
10.6 Novartis AG
10.7 Pfizer Inc.
10.8 Teva Pharmaceutical Industries Ltd.
10.9 Cadila Pharmaceuticals
10.10 Cellceutix Corporation

網膜芽細胞腫治療市場規模：疾患タイプ、病期、治療タイプ、エンドユーザー別＆世界予測、2024年～2032年

Retinoblastoma Treatment Market Size - By Disease Type (Non-hereditary, Hereditary), Disease Stage (Intraocular, Extraocular), Treatment Type (Chemotherapy, Radiation, Surgery, Laser, Cryotherapy), End-user & Global Forecast, 2024 - 2032

目次

第1章調査手法と調査範囲

第2章エグゼクティブサマリー

第3章網膜芽細胞腫治療市場の洞察

第4章競合情勢

第5章網膜芽細胞腫治療市場推定・主要動向予測：疾患タイプ別、2018年～2032年

第6章網膜芽細胞腫治療市場の推定・予測：病期別、2018-2032年

第7章網膜芽細胞腫治療市場の推定・予測：治療タイプ別、2018-2032年

第8章網膜芽細胞腫治療市場推計・予測：エンドユーザー別、2018年～2032年

第9章網膜芽細胞腫治療市場の推定・予測：地域別、2018年～2032年

第10章企業プロファイル

Data Tables

Charts & Figures

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Retinoblastoma Treatment Market Insights

Chapter 4 Competitive Landscape, 2023

Chapter 5 Retinoblastoma Treatment Market Estimates and Forecast, By Disease Type, 2018-2032 (USD Million)

Chapter 6 Retinoblastoma Treatment Market Estimates and Forecast, By Disease Stage, 2018-2032 (USD Million)

Chapter 7 Retinoblastoma Treatment Market Estimates and Forecast, By Treatment Type, 2018-2032 (USD Million)

Chapter 8 Retinoblastoma Treatment Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)

Chapter 9 Retinoblastoma Treatment Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

Chapter 10 Company Profiles

網膜芽細胞腫治療市場規模：疾患タイプ、病期、治療タイプ、エンドユーザー別＆世界予測、2024年～2032年

Retinoblastoma Treatment Market Size - By Disease Type (Non-hereditary, Hereditary), Disease Stage (Intraocular, Extraocular), Treatment Type (Chemotherapy, Radiation, Surgery, Laser, Cryotherapy), End-user & Global Forecast, 2024 - 2032

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 網膜芽細胞腫治療市場の洞察

第4章 競合情勢

第5章 網膜芽細胞腫治療市場推定・主要動向予測：疾患タイプ別、2018年～2032年

第6章 網膜芽細胞腫治療市場の推定・予測：病期別、2018-2032年

第7章 網膜芽細胞腫治療市場の推定・予測：治療タイプ別、2018-2032年

第8章 網膜芽細胞腫治療市場推計・予測：エンドユーザー別、2018年～2032年

第9章 網膜芽細胞腫治療市場の推定・予測：地域別、2018年～2032年

第10章 企業プロファイル

Data Tables

Charts & Figures

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Retinoblastoma Treatment Market Insights

Chapter 4 Competitive Landscape, 2023

Chapter 5 Retinoblastoma Treatment Market Estimates and Forecast, By Disease Type, 2018-2032 (USD Million)

Chapter 6 Retinoblastoma Treatment Market Estimates and Forecast, By Disease Stage, 2018-2032 (USD Million)

Chapter 7 Retinoblastoma Treatment Market Estimates and Forecast, By Treatment Type, 2018-2032 (USD Million)

Chapter 8 Retinoblastoma Treatment Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)

Chapter 9 Retinoblastoma Treatment Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

Chapter 10 Company Profiles

第1章調査手法と調査範囲

第2章エグゼクティブサマリー

第3章網膜芽細胞腫治療市場の洞察

第4章競合情勢

第5章網膜芽細胞腫治療市場推定・主要動向予測：疾患タイプ別、2018年～2032年

第6章網膜芽細胞腫治療市場の推定・予測：病期別、2018-2032年

第7章網膜芽細胞腫治療市場の推定・予測：治療タイプ別、2018-2032年

第8章網膜芽細胞腫治療市場推計・予測：エンドユーザー別、2018年～2032年

第9章網膜芽細胞腫治療市場の推定・予測：地域別、2018年～2032年

第10章企業プロファイル